High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: A clinicopathologic study of 28 cases

American Journal of Surgical Pathology

Volumn 32, Issue 7, 2008, Pages 1060-1067

  Tavora, Fabio ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Ductal adenocarcinoma of the prostate; High grade intraepithelial neoplasia; Prostate cancer

Indexed keywords

ACYL COENZYME A; PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TUMOR MARKER;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; TUMOR NECROSIS; BLOOD; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RADIOTHERAPY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY, NEEDLE; CARCINOMA, DUCTAL; CRYOTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RADIOTHERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 47249101679     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318160edaf     Document Type: Article

References (12)

1. Amin MB, Cabrera RA, Lim SD. All that is micropapillary is not high-grade prostatic intraepithelial neoplasia (HG-PIN): Circumferential micropapillary perineural invasion (CMPNI) - a potential pitfall in the recognition of invasive prostatic adenocarcinoma. Mod Pathol. 2003;15:139.
2. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781-785.
3. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarci-noma with endometrioid features. Clinical, pathologic, and ultra-structural findings. Am J Surg Pathol. 1985;9:595-609.
4. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471-1479.
5. Christensen WN, Steinberg G, Walsh PC, et al. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991;67:2118-2124.
6. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochem-ical study of ten cases. Cancer. 1986;57:111-119.
7. Epstein JI, Netto GJ. Prostate Biopsy Interpretation. 4th ed. Lippincott Williams and Wilkins; 2002:54-57-218-227.
8. Epstein JI, Allsbrook WC Jr, Amin MB, et al. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol. 2006; 13:57-59.
9. Greene LF, Farrow GM, Ravits JM, et al. Prostatic adenocarci-noma of ductal origin. J Urol. 1979;121:303-305.
10. Hameed O, Humphrey PA. Stratified epithelium in prostatic adenocarcinoma: a mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2006;19:899-906.
11. Herawi M, Epstein JI. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarci-nomas of the prostate. Am J Surg Pathol. 2007;31:889-894.
12. Ro JY, Ayala AG, Wishnow KI, et al. Prostatic duct adeno-carcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol. 1988;5:301-311.